These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37042152)
21. A report of two cases of dedifferentiated endometrioid carcinoma: A newly described underrecognized tumor of poor prognosis. Boler AK; Akhtar S; Bandyopadhyay A; Roy S Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S91-S93. PubMed ID: 32108637 [TBL] [Abstract][Full Text] [Related]
22. p53, estrogen and progesterone receptors in diagnostic curettage for endometrial adenocarcinoma and their correlation with morphological data and disease stage at hysterectomy. Bonfitto VL; de Angelo Andrade LA Sao Paulo Med J; 2003 Jul; 121(4):163-6. PubMed ID: 14595509 [TBL] [Abstract][Full Text] [Related]
23. Nuclear features in endometrial cytology: comparison of endometrial glandular and stromal breakdown and endometrioid adenocarcinoma grade 1. Norimatsu Y; Shigematsu Y; Sakamoto S; Ohsaki H; Yanoh K; Kawanishi N; Kobayashi TK Diagn Cytopathol; 2012 Dec; 40(12):1077-82. PubMed ID: 22241733 [TBL] [Abstract][Full Text] [Related]
24. Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review. Liang SX; Patel K; Pearl M; Liu J; Zheng W; Tornos C Int J Gynecol Pathol; 2007 Jul; 26(3):291-7. PubMed ID: 17581414 [TBL] [Abstract][Full Text] [Related]
25. Epithelioid endometrial and endometrioid stromal tumors: a report of four cases emphasizing their distinction from epithelioid smooth muscle tumors and other oxyphilic uterine and extrauterine tumors. Oliva E; Clement PB; Young RH Int J Gynecol Pathol; 2002 Jan; 21(1):48-55. PubMed ID: 11781523 [TBL] [Abstract][Full Text] [Related]
26. How to approach the many faces of endometrioid carcinoma. Malpica A Mod Pathol; 2016 Jan; 29 Suppl 1():S29-44. PubMed ID: 26715172 [TBL] [Abstract][Full Text] [Related]
27. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion. Tambouret R; Clement PB; Young RH Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240 [TBL] [Abstract][Full Text] [Related]
28. Minimal deviation endometrioid adenocarcinoma of the endometrium and its MRI findings. Nakao Y; Yamasaki F; Yokoyama M; Aihara S; Yasunaga M; Iwasaka T Eur J Gynaecol Oncol; 2014; 35(2):185-7. PubMed ID: 24772926 [TBL] [Abstract][Full Text] [Related]
29. Sertoliform endometrial adenocarcinoma: a study of four cases. Eichhorn JH; Young RH; Clement PB Int J Gynecol Pathol; 1996 Apr; 15(2):119-26. PubMed ID: 8786200 [TBL] [Abstract][Full Text] [Related]
30. Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma? Silva EG; Deavers MT; Bodurka DC; Malpica A Int J Gynecol Pathol; 2006 Jan; 25(1):52-8. PubMed ID: 16306785 [TBL] [Abstract][Full Text] [Related]
31. Complete Histologic Regression of Endometrioid Adenocarcinoma on Endometrial Biopsy After Progestin Treatment Does Not Guarantee the Regression of an Invasive Carcinoma Within the Myometrium. Park JY; Park JY; Nam JH; Kim KR Int J Gynecol Pathol; 2019 Jan; 38(1):66-70. PubMed ID: 29257040 [TBL] [Abstract][Full Text] [Related]
32. Undifferentiated Carcinoma of the Endometrium: An Expanded Immunohistochemical Analysis Including PAX-8 and Basal-Like Carcinoma Surrogate Markers. Ramalingam P; Masand RP; Euscher ED; Malpica A Int J Gynecol Pathol; 2016 Sep; 35(5):410-8. PubMed ID: 26598976 [TBL] [Abstract][Full Text] [Related]
33. Primary sex cord-like variant of endometrioid adenocarcinoma arising from endometriosis. Kauppila S; Altinörs M; Väre P; Liakka A; Knuuti E; Nissi R APMIS; 2008 Sep; 116(9):842-5. PubMed ID: 19024607 [TBL] [Abstract][Full Text] [Related]
34. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience. Park CK; Yoon G; Cho YA; Kim HS Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430 [TBL] [Abstract][Full Text] [Related]
35. Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability. Aysal A; Karnezis A; Medhi I; Grenert JP; Zaloudek CJ; Rabban JT Am J Surg Pathol; 2012 Feb; 36(2):163-72. PubMed ID: 22189970 [TBL] [Abstract][Full Text] [Related]
36. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions]. Xiong Y; Xiong YY; Zhou YF Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187 [TBL] [Abstract][Full Text] [Related]
37. Endometrioid endometrial adenocarcinoma with psammoma bodies. Parkash V; Carcangiu ML Am J Surg Pathol; 1997 Apr; 21(4):399-406. PubMed ID: 9130986 [TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic study of endometrial dedifferentiated endometrioid adenocarcinoma: a case report. Shen Y; Wang Y; Shi Y; Liu J; Liu Y Int J Clin Exp Pathol; 2012; 5(1):77-82. PubMed ID: 22295150 [TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma. Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767 [TBL] [Abstract][Full Text] [Related]